# US 2017/0253913 A1 · Systems, devices, and methods for deploying onboard reagents in a diagnostic device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0253913 A1
- Document ID: US20170253913A1
- Status: Published application
- Kind: A1
- Application number: 15/464,464
- Filed: 2017-03-21
- Published: 2017-09-07
- Earliest claimed: 2013-08-07
- Applicants: Xagenic Inc.
- Inventors: Graham D. JACK; Susan BORTOLIN
- Web page: https://patentgrep.com/patent/US20170253913A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- B01L 3/5027: {by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip}
- B01L 2200/10: Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
- B01L 2200/16: Reagents, handling or storing thereof
- B01L 2300/0816: Cards, e.g. flat sample carriers usually with flow in two horizontal directions
- B01L 2400/0487: fluid pressure, pneumatics
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE

## Abstract

Disclosed herein are systems, devices, and methods for detecting the presence of a pathogen in a biological host, such as in a point of care setting. In certain aspects, materials and methods improve point of care devices by providing pre-loaded, preferably dried, agents for performing one or more of sample lysis and signal enhancement inside the device.

## Claims

### Claim 1

A chamber located within a point of care device, wherein the chamber includes at least one agent in dry form.

### Claim 2 (depends on 1)

The chamber of claim 1, wherein the chamber is a lysis chamber disposed between an inlet port of the device and a probe positioned within the device, the lysis chamber having at least one chemical lysing agent disposed therein.

### Claim 3 (depends on 2)

The chamber of claim 2, wherein the at least one chemical lysing agent is in dry form.

### Claim 4 (depends on 2)

The chamber of claim 2, wherein the at least one chemical lysing agent is dried to an interior surface of the lysis chamber.

### Claim 5 (depends on 1)

The chamber of any claim 1, wherein the lysis chamber includes first and second chambers and a flow line disposed between the first and second chambers and through which fluid flows from the first to the second chamber.

### Claim 6 (depends on 5)

The chamber of claim 5, wherein the first chamber includes a chemical lysing agent and the second chamber includes a neutralizing agent.

### Claim 7 (depends on 6)

The chamber of claim 6, wherein the chemical lysing agent is a base and the neutralizing agent is an acid.

### Claim 8 (depends on 6)

The chamber of claim 6, wherein the chemical lysing agent is an acid and the neutralizing agent is a base.

### Claim 9

(canceled)

### Claim 10 (depends on 5)

The chamber of claim 5, wherein a base is dried to an interior surface of the first chamber and an acid is dried to an interior wall of the second chamber.

### Claim 11 (depends on 7)

The chamber of claim 7, wherein a fluid sample includes cells containing genetic material and, upon the fluid sample's contacting the base in the first chamber, the fluid sample forms a lysate comprising lysed cells and fragments of the genetic material, the lysate having a basic pH.

### Claim 12 (depends on 11)

The chamber of claim 11, wherein the fragments of the genetic material are partial fragments of the genetic material.

### Claim 13 (depends on 11)

The chamber of claim 11, wherein the lysate flows out of the second chamber having a pH that is less basic than the pH of the lysate that exits the first chamber.

### Claim 14 (depends on 13)

The chamber of claim 13, wherein the lysate flowing out of the second chamber has a neutral pH.

### Claim 15 (depends on 2)

The chamber of claim 2, wherein the chemical lysing agent is mixed with a detergent.

### Claim 16 (depends on 1)

The chamber of claim 1, comprising a catalytic agent dried to an interior surface of the chamber.

### Claim 17

A point of care device having:
an inlet port through which a fluid sample flows, a probe chamber, and;
a chamber according to any of the preceding claims.

### Claim 18 (depends on 17)

The point of care device of claim 17, wherein the chamber is a lysis chamber.

### Claim 19 (depends on 17)

The point of care device of claim 17, wherein the chamber is a catalytic agent chamber and contains one or more electrochemical agents configured to amplify an electrochemical signal arising from the device.

### Claim 20 (depends on 19)

The device of claim 19, wherein the electrochemical agents include at least Ru(NH3)63+ or Fe(CN)63−.

### Claim 21

A method of preparing a biological sample for analysis of its nucleic acid material, comprising the steps of:
(i) combining the biological sample in a buffer to form a first solution at a first pH,
(ii) flowing the first solution into contact with a first chemical agent that changes the pH of the first solution, forming a second solution at a second pH, and;
(iii) flowing the second solution into contact with a second chemical agent that changes the pH to a level that is less basic or less acidic than the second pH.
